World's Best Scientists 2026 revealed!
Richard M. Bergenstal

Richard M. Bergenstal

D-Index & Metrics

Medicine

D-Index
101
Citations
60575
World Ranking
7802
National Ranking
4068

Overview

Richard M. Bergenstal is affiliated with HealthPartners in the United States. Their research primarily spans the field of Medicine with a strong focus on Endocrinology, Diabetes, and Metabolism. With a publication record emphasizing diabetes management and treatment, Bergenstal's work contributes to clinical practices and advances in automated insulin delivery and glucose monitoring technologies.

Their research covers several main topics including:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Diabetes Management and Education
  • Diet and metabolism studies

Frequent co-authors include:

  • Roy W. Beck
  • Anders L. Carlson
  • Tadej Battelino
  • Mary L. Johnson
  • Thomas W. Martens

Bergenstal's publications are found extensively in the following venues:

  • Diabetes
  • Diabetes Technology & Therapeutics
  • Journal of Diabetes Science and Technology
  • Diabetes Care
  • UNC Libraries

Notable recent papers authored or co-authored by Bergenstal include:

  • "Continuous glucose monitoring and metrics for clinical trials: an international consensus statement" (2022) published in The Lancet Diabetes & Endocrinology
  • "Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin" (2021) published in JAMA
  • "Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice" (2022) published in Endocrine Reviews
  • "A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial" (2021) published in The Lancet
  • "Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes" (2021) published in Diabetes Care

In addition to research articles, Bergenstal has contributed to book publications, including a title released by La Trobe University titled "Role of Continuous Glucose Monitoring in Diabetes Treatment" (2020).

Best Publications

  • Diabetes and Cancer: A consensus report

    Edward L. Giovannucci;David M. Harlan;Michael C. Archer;Richard M. Bergenstal

  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    Silvio E Inzucchi;Richard M Bergenstal;John B Buse;Michaela Diamant

  • Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

    William B. White;Christopher P. Cannon;Simon R. Heller;Steven E. Nissen

  • Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Tadej Battelino;Thomas Danne;Richard M. Bergenstal;Stephanie A. Amiel

  • Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Current State of Type 1 Diabetes Treatment in the U.S.: Updated Data From the T1D Exchange Clinic Registry

    Kellee M. Miller;Nicole C. Foster;Roy W. Beck;Richard M. Bergenstal

  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379

    SE Inzucchi;RM Bergenstal;JB Buse;M Diamant

  • The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

    Denise E Bonds;Michael E Miller;Richard M Bergenstal;John B Buse

  • Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

    Richard M. Bergenstal;William V. Tamborlane;Andrew Ahmann;John B. Buse

  • Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.

    Roy W Beck;Tonya Riddlesworth;Katrina Ruedy;Andrew Ahmann

  • Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial

    Melanie J. Davies;Richard Bergenstal;Bruce Bode;Robert F. Kushner

  • Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

    Richard M Bergenstal;Carol Wysham;Leigh MacConell;Jaret Malloy

  • Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

    Silvio E. Inzucchi;Richard M. Bergenstal;John B. Buse;Michaela Diamant

  • Threshold-based insulin-pump interruption for reduction of hypoglycemia

    Richard M. Bergenstal;David C. K Klonoff;Satish K. Garg;Bruce W. Bode

  • A new look at screening and diagnosing diabetes mellitus

    Christopher D. Saudek;William H. Herman;David B. Sacks;Richard M. Bergenstal

  • Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.

    Roy W. Beck;Richard M. Bergenstal;Tonya D. Riddlesworth;Craig Kollman

  • Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

    Richard M. Bergenstal;Satish Garg;Stuart A. Weinzimer;Bruce A. Buckingham

  • Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.

    John B Buse;Richard M Bergenstal;Leonard C Glass;Cory R Heilmann

  • Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

    Satish K Garg;Stuart A Weinzimer;William V Tamborlane;Bruce A Buckingham

  • Erratum: Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (Diabetologia (2013) 56 (680))

    S. E. Inzucchi;R. M. Bergenstal;John B Buse;M. Diamant

Frequent Co-Authors

Roy W. Beck
Roy W. Beck University of South Florida
Anne L. Peters
Anne L. Peters University of Southern California
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Geremia B. Bolli
Geremia B. Bolli University of Perugia
Simon Heller
Simon Heller University of Sheffield
Irl B. Hirsch
Irl B. Hirsch University of Washington
William V. Tamborlane
William V. Tamborlane Yale University
Satish K. Garg
Satish K. Garg University of Colorado Anschutz Medical Campus
David R. Matthews
David R. Matthews University of Oxford
Philip Home
Philip Home Newcastle University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always follow a single path. There are several online degree options and career pathways for those passionate about healthcare. For registered nurses looking to advance their expertise, an rn to np bridge program allows for a seamless transition to become a nurse practitioner.

If your interests lie in health and wellness, an online nutritionist degree offers a flexible route to entering the field of nutrition and dietetics. For those aiming for leadership or management roles in healthcare, cahme accredited online mha programs are designed to provide quality education in healthcare administration without disrupting your current career.

Additionally, career advancement for nurses has become more accessible with rn to bsn programs that require no clinicals, making it easier than ever to earn a bachelor’s degree online. These options create flexible opportunities to grow your qualifications and expand your career in medicine and beyond.

Best Scientists Citing Richard M. Bergenstal

Trending Scientists